Headache in children
218 results
101 - 200
Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children
Fever in a child - Conservative interventions for treating functional daytime urinary incontinence in children
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for cancer‐related pain in children and adolescents
- Vaccines for preventing typhoid fever
- Viral infections of the oral mucosa
Pragmatic trial: Oseltamivir of uncertain benefit in patients with flu-like symptoms- Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria: Cochrane systematic review
- Useful history, physical, and laboratory findings for predicting secondary hypertension in children and adolescents
- Intracystic bleomycin for cystic craniopharyngiomas in children
- AAN Guidelines on medications for acute treatment and prevention of migraine in children and adolescents
- E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions
- Pharmacologic treatment of depression in multiple sclerosis
- Osmotic and stimulant laxatives for the management of childhood constipation
- Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma
- Keratitis
- Fluoride gels for preventing dental caries in children and adolescents
- Anthelmintic drugs for treating ascariasis
- Minimal and mild traumatic brain injury
- Stomatitis in children
- Rate of new-onset seizures is less than 0.01% among SARS-CoV-2 vaccine recipients and placebo recipients
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
- Renal disease in children (nephrotic and nephritic syndrome)
- Non‐steroidal anti‐inflammatory drugs for the common cold
- Interventions for morphea
- Vitamin C for preventing and treating the common cold
- AAN guideline for treating insomnia in children and adolescents with autism spectrum disorder
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- COVID-19 and other coronavirus infections
- Oral xanthines as maintenance treatment for asthma in children
- Tricyclic and related drugs for nocturnal enuresis in children
- Oral evening primrose oil and borage oil for eczema
- Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community‐acquired pneumonia
- Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting
- Cyclamen europaeum extract for acute sinusitis
- Homeopathic Oscillococcinum® for preventing and treating influenza and influenza‐like illness
- Interventions for morphea
- Vision screening for correctable visual acuity deficits in school‐age children and adolescents
- Vaccines for preventing malaria
- Vaccines for preventing malaria (pre‐erythrocytic)
- Vaccines for preventing Japanese encephalitis
- Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma
- Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins
- Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma: Cochrane systematic review
- Immunomodulatory interventions for focal epilepsy
- Viral diseases in warm climates
- Combination of inhaled long-acting beta-2 agonists and inhaled steroids versus higher dose of inhaled steroids in persistent asthma
- Low dose naltrexone for induction of remission in Crohn's disease
- Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria: Cochrane systematic review
- Antibiotics versus placebo for acute bacterial conjunctivitis
- Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid: Cochrane systematic review
- Magnesium for treating sickle cell disease
- Lacosamide add‐on therapy for focal epilepsy
- Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
- Non surgical therapy for anal fissure: Cochrane systematic review
- Impaired vision
- Peripheral facial paralysis
- Rufinamide add‐on therapy for drug‐resistant epilepsy
- Antibiotics for community-acquired pneumonia in adult outpatients: Cochrane systematic review
- Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema
- Antiepileptic drugs for chronic non‐cancer pain in children and adolescents
- Macrolide antibiotics (including azithromycin) for cystic fibrosis
- Ginkgo biloba for tinnitus
- Bacterial diseases in warm climates
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents
- Vigabatrin add‐on therapy for drug‐resistant focal epilepsy
- Interventions for chronic pruritus of unknown origin
- Childhood depression
- Phosphodiesterase 5 inhibitors for pulmonary hypertension
- Pharmacological intervention for irritability, aggression, and self‐injury in autism spectrum disorder (ASD)
- Vagus nerve stimulation for focal seizures
- Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19
- Vitamins
- Leukotriene receptor antagonists for eczema
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Melatonin as add‐on treatment for epilepsy
- Prostacyclin for pulmonary arterial hypertension
- Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour
- Efficacy and safety of COVID‐19 vaccines
- Interventionist versus expectant care for severe pre‐eclampsia between 24 and 34 weeks' gestation
- Anthelmintics for people with neurocysticercosis
- Interventions for reducing inflammation in familial Mediterranean fever
- Tocolytics for delaying preterm birth: a network meta‐analysis (0924)
- Interventions for hand eczema
- Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma
- Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data